Alabama Statutes
§ 20-2-114 — Controlled Substances Therapeutic Research Program - Limited to Cancer Chemotherapy and Glaucoma Patients; Certification; Exemption from Prosecution
Except as herein otherwise provided, the Controlled Substances Therapeutic Research Program shall be limited to cancer chemotherapy patients and glaucoma patients, who are certified to the review committee by an authorized practitioner as being in such medical condition necessary for the treatment of glaucoma, or the side effects of chemotherapy in cancer patients; such authorization shall be upon such terms and conditions as may be consistent with the public health and safety. To the extent of the applicable authorization, persons are exempt from prosecution in this state for possession, production, manufacture, or delivery of cannabis.
Free access — add to your briefcase to read the full text and ask questions with AI
Alabama § 20-2-114 (Controlled Substances Therapeutic Research Program - Limited to Cancer Chemotherapy and Glaucoma Patients; Certification; Exemption from Prosecution) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
(Acts 1979, No. 79-472, p. 870, §5.)
Nearby Sections
15
§ 20-1-110
Short Title§ 20-1-113
Requirements as to Labeling§ 20-1-130
Definitions Generally§ 20-1-131
Purpose of Article§ 20-1-132
Definition and Standards for Mellorine§ 20-1-134
Requirements as to Sale Generally§ 20-1-136
False and Misleading Advertising§ 20-1-140
Definitions